1）Impact of central and peripheral estrogen treatment on anxiety and depression phenotypes in a mouse model of postmenopausal obesity.
Wada T, Sameshima A, Yonezawa R, Morita M, Sawakawa K, Tsuneki H, Sasaoka T, Saito S.
PLoS One. 13: e0209859, 2018.

2）Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders.
Tsuneki H, Wada T, Sasaoka T.
Pharmacol Ther. 186: 25-44, 2018.